Michael R. Bristow
2021
In 2021, Michael R. Bristow earned a total compensation of $526.5K as President and Chief Executive Officer at ARCA biopharma, a 50% decrease compared to previous year.
Compensation breakdown
| Option Awards | $162,956 |
|---|---|
| Salary | $343,431 |
| Other | $20,126 |
| Total | $526,513 |
Bristow received $343.4K in salary, accounting for 65% of the total pay in 2021.
Bristow also received $163K in option awards and $20.1K in other compensation.
Rankings
In 2021, Michael R. Bristow's compensation ranked 10,612th out of 12,397 executives tracked by ExecPay. In other words, Bristow earned more than 14.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,612 out of 12,397 | 14th |
Division Manufacturing | 4,684 out of 5,492 | 15th |
Major group Chemicals And Allied Products | 2,104 out of 2,367 | 11th |
Industry group Drugs | 1,870 out of 2,090 | 11th |
Industry In Vitro and In Vivo Diagnostic Substances | 49 out of 61 | 20th |
Source: SEC filing on November 3, 2022.
Bristow's colleagues
We found two more compensation records of executives who worked with Michael R. Bristow at ARCA biopharma in 2021.
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019